出版倫理
出版倫理と不正行為に関する声明
Journal of Clinical & Experimental Dermatology Research は倫理事項と誤りを遵守し、必要に応じて法的審査も行います。ジャーナルは、再版や広告が編集者の決定に影響を与えないことを保証します。ジャーナルの編集委員会では、接続のリクエストに応じて、他の出版社、ジャーナル、著者と通信することができます。
著者の責任
著者には、作品の意義とともに誠実な態度で作品の説明を提示することが求められます。著者はオリジナルの著作物を発表することが期待されており、他者の著作物を引用する場合には適切な引用を行う必要があります。
著者は、一次出版物またはジャーナルの複数の原稿に同じ研究を含めるべきではありません。報告される作業範囲は、影響を与えている他の出版物からの適切な引用に基づいている必要があります。
原稿内の発見や研究を支配する金銭的または個人的な利益は、財政的支援とその資金源の詳細とともに明らかにされるべきです。
査読者の責任
Reviewer is responsible to both the author and the editor in regard to the manuscript. Peer review is the principal mechanism by which the quality of research is judged. Most funding decisions in science and the academic advancement of scientists are based on peer-reviewed publications.
Ethical Responsibilities of Reviewers
- Confidentiality: - Reviews and reviewer comments should be held confidentially. Manuscripts or copies of the process should not be retained with the reviewers after the process is commenced
- Constructive Evaluation: - Decisions and judgment should be constructive that provides legible insight to author without any controversy or inefficiencies with the review process
- Competence: -Reviewer with passable expertise will serve the purpose to complete the review. People lacking adequate expertise should feel responsible and can decline the review.
- Impartiality and Integrity: - Reviewer decision should solely depend on scientific merit, relevance to the subject, scope of the journal rather on financial, racial, ethnic origin etc of the authors.
- Timeliness and Responsiveness: - Reviewer should be responsible to complete the review within the relevant time and should take all necessary steps to fulfill the limitations of the journal.
Responsibilities of the Editor and Editorial Board
Publication decisions: The decision to publish an article submitted to the Journal of Clinical & Experimental Dermatology Research is taken by the editorial board. The editor must stick to the contemporary regulations pertaining to libel, copyright infringement and plagiarism that are effective. He is entitled to carry out decision-making in consultation with reviewers or members of the editorial board.
Fair play: an editor should evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.
Confidentiality: the editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Guidelines for retracting articles
Journal of Clinical & Experimental Dermatology Research takes its responsibility to maintain the integrity and completeness of the scholarly record of our content for all end users very seriously. Journal of Clinical & Experimental Dermatology Research places great importance on the authority of articles after they have been published and our policy is based on best practice in the academic publishing community.
It is a general principle of scholarly communication that the editor of a learned journal is solely and independently responsible for deciding which articles submitted to the journal shall be published. In making this decision, the editor is guided by the policies of the journal's editorial board and constrained by such legal requirements in force regarding libel, copyright infringement and plagiarism. An outcome of this principle is the importance of the scholarly archive as a permanent, historic record of the transactions of scholarship. Articles that have been published shall remain extant, exact and unaltered as far as is possible. However, very occasionally circumstances may arise where an article is published that must later be retracted or even removed. Such actions must not be undertaken lightly and can only occur under exceptional circumstances, such as:
Article Withdrawal: Only used for Articles in Press which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, but less frequently, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like.
Article Retraction: Infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Occasionally a retraction will be used to correct errors in submission or publication.
Article Removal: Legal limitations upon the publisher, copyright holder or author(s).
Article Replacement: Identification of false or inaccurate data that, if acted upon, would pose a serious health risk.
Maintain the integrity of the academic record
Encouraging academic integrity
Request evidence of ethical research approval for all relevant submissions and be prepared to question authors about aspects such as how patient consent was obtained or what methods were employed to minimize animal suffering.
Ensure that reports of clinical trials cite compliance with the Declaration of Helsinki, Good Clinical Practice and other relevant guidelines to safeguard participant.
Ensure that reports of experiments on, or studies of, animals cite compliance with the US Department of Health and Human Services Guide for the Care and Use of Laboratory Animals or other relevant guidelines.
特定のケースについてアドバイスし、定期的にジャーナルのポリシーをレビューするジャーナル倫理委員会を任命することを検討してください。
学業成績の完全性の確保
すべての臨床試験の登録を義務付けるなど、秘密裏の重複出版を減らす措置を講じます。
公開された資料が安全にアーカイブされていることを確認します (例: PubMed Central などのオンラインの永久リポジトリ経由)。
著者にオリジナルの研究論文を自由に利用できるようにする機会を与えるシステムを整備します。
ビジネス ニーズが知的基準と倫理基準を侵害することを防ぎます。
誤り、不正確または誤解を招く記述は、直ちに、適切な注意を払って修正する必要があります。編集者は撤回に関するCOPEガイドラインに従う必要があります。